marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-14-2023
Bellerophon Therapeutics Financial Ratios 2011-2024 | BLPH
Annual Financial Ratios Bellerophon Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.0 | -1.3 | -2.2 | - | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.1 | -1.9 | -3.2 | -3.0 | 0.7 | -21.1 | -1.6 | -3.8 | -7.6 | - | - | - |
EV (Enterprise Value) |
77.1 M | 3.04 M | 18.4 M | 23.4 M | 37.8 M | 100 M | 7.2 M | 30.2 M | -6.36 M | 19.4 M | 14.5 M | - |
EBITDA per Share |
-2.34 | -2.12 | -3.37 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.0 | -0.7 | - | - | - | - | - | - | - | - | - | |
PEG |
- | 0.03 | - | - | - | - | - | - | - | - | - | |
P/B |
31.0 | 1.0 | 1.4 | 6.6 | 10.4 | -34.5 | 0.6 | 0.9 | - | - | - | - |
P/CF |
-4.4 | -1.0 | -2.7 | -1.8 | -2.6 | -5.7 | -0.6 | -0.6 | - | - | - | - |
ROE % |
-782.60 | -82.13 | -64.65 | - | - | - | - | - | - | - | - | - |
ROA % |
-249.92 | -66.07 | -49.22 | - | - | - | - | - | - | - | - | - |
ROCE % |
-883.35 | -93.26 | -68.70 | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.5 | 5.1 | 4.2 | 1.4 | 2.3 | 5.0 | 4.1 | 3.6 | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Bellerophon Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.16 | -0.42 | 0.27 | - | -0.53 | -0.43 | -0.59 | - | -0.49 | -0.36 | -0.58 | -0.84 | -0.84 | -0.51 | -1.08 | -0.89 | -0.94 | -0.9 | -0.18 | -0.24 | 2.89 | -3.01 | 1.08 | -0.44 | -0.22 | -0.12 | -0.6 | -0.37 | -0.3 | -0.39 | -0.54 | -0.83 | -0.86 | -0.9 | -1.27 | -1.62 | -1.96 | -2.14 | -1.84 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.18 | -0.43 | 0.14 | - | -0.54 | -0.69 | -0.59 | - | -0.51 | -0.55 | -0.62 | -0.86 | -0.87 | -0.76 | -0.89 | -0.94 | -1.01 | -0.93 | -1 | -1.22 | -1.78 | -2.06 | -2.23 | -0.13 | -0.18 | -0.19 | -0.15 | -0.36 | -0.3 | -0.39 | -0.54 | -0.83 | -0.87 | -0.9 | -1.27 | -1.62 | -1.96 | -2.15 | -1.84 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-184.60 | -201.24 | -143.29 | -136.56 | -154.52 | -104.25 | -82.08 | -45.71 | -66.64 | -69.41 | -68.14 | -64.65 | -157.34 | -255.98 | -360.31 | -369.45 | 32.05 | 439.33 | 256.15 | 96.63 | 1027.97 | 1032.53 | 1481.51 | 2113.26 | 1140.66 | 824.90 | 644.85 | -132.36 | -126.79 | -140.20 | -149.83 | -153.15 | -173.13 | -203.89 | -239.45 | -260.16 | -204.49 | -137.01 | -63.26 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-106.80 | -108.43 | -85.89 | -89.30 | -104.10 | -78.69 | -64.68 | -36.88 | -52.81 | -53.81 | -52.27 | -49.22 | -64.41 | -81.33 | -105.04 | -101.21 | -9.62 | 83.54 | 52.38 | 20.29 | -45.34 | -126.41 | -74.61 | -148.92 | -108.28 | -101.80 | -108.42 | -80.18 | -83.37 | -98.26 | -111.12 | -120.96 | -131.01 | -148.36 | -168.86 | -178.71 | -140.47 | -94.11 | -43.45 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-206.74 | -217.33 | -177.06 | -157.03 | -175.65 | -125.40 | -89.50 | -53.67 | -74.97 | -77.94 | -75.64 | -68.70 | -167.56 | -273.81 | -376.41 | -486.58 | -487.89 | -537.19 | -623.71 | -723.03 | -319.79 | 95.76 | 543.69 | 948.30 | 626.01 | 364.17 | 91.75 | -132.04 | -127.32 | -140.70 | -150.30 | -153.51 | -173.45 | -204.18 | -239.86 | -260.51 | -204.76 | -137.21 | -63.26 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.0 | 2.0 | 3.0 | 1.5 | 2.4 | 3.2 | 3.9 | 5.1 | 5.7 | 5.3 | 4.7 | 4.2 | 4.2 | 4.2 | 4.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 0.9 | 0.9 | 0.9 | 0.9 | 2.5 | 2.5 | 2.5 | 2.5 | 4.8 | 4.8 | 4.8 | 4.8 | 3.2 | 3.2 | 3.2 | 3.2 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency